FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Bionik Laboratories's FCF Yield % or its related term are showing as below:
BNKL's FCF Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.57 * Ranked among companies with meaningful FCF Yield % only.
The historical data trend for Bionik Laboratories's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bionik Laboratories's FCF Yield %
For the Medical Care Facilities subindustry, Bionik Laboratories's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionik Laboratories's FCF Yield % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Bionik Laboratories's FCF Yield % falls into.
Bionik Laboratories FCF Yield % Calculation
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Bionik Laboratories's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionik Laboratories FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bionik Laboratories FCF Yield % Related Terms
Thank you for viewing the detailed overview of Bionik Laboratories's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bionik Laboratories (Bionik Laboratories) Business Description
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BNKL has been successfully added to your 